Rapamycin inhibited AML cell viability and cell cycle process and induced apoptosis through regulation of the circ_0094100/miR-217/ATP1B1 axis.
Rapamycin inhibits the progression of human acute myeloid leukemia by regulating the circ_0094100/miR-217/ATP1B1 axis.